Lupus clinical research study
Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that can affect various parts of the body, including the skin, joints, kidneys, and other organs. It is estimated that about 5 million people worldwide suffer from lupus, and it is more common in women than men. Symptoms can vary widely from person to person and can include joint pain, skin rashes, fever, fatigue, and kidney problems. There is no cure for SLE, but treatment can help manage the symptoms and prevent damage to the organs. Treatment options may include medications, lifestyle changes, and in some cases, surgery.
CRP is now enrolling participants with moderate to severe lupus for a clinical trial exploring the safety and efficacy of a new investigational drug
Get started now
People diagnosed with SLE
Between 18-75 years of age (inclusive)
Taking at least one SLE treatment (e.g. Hydroxychloroquine)
Who is it for?
Study-related medication
Exams & lab work at no cost
If you qualify, you may be compensated for time and travel